ALAB CEO Mohan Jitendra discloses Rule 10b5-1 stock sales
Rhea-AI Filing Summary
Mohan Jitendra, Chief Executive Officer and director of Astera Labs (ALAB), reported sales of company common stock on 08/07/2025 executed under a Rule 10b5-1 trading plan adopted December 2, 2024. The Form 4 discloses a weighted average sale price of $170.3278 and lists lot-level price ranges and quantities for the transactions in a detailed footnote.
The filing also discloses amounts held indirectly by trusts: a Living Trust with 4,280,002 shares; a Trust with 699,999 shares; 2021 Trusts 1 and 2 with 700,000 shares each; and 2022 Trusts 1 and 2 with 450,001 shares each. The reporting person disclaims beneficial ownership of those trust holdings except to the extent of any pecuniary interest.
Positive
- Sales executed under a Rule 10b5-1 plan, reducing questions about opportunistic timing (plan adopted December 2, 2024).
- Weighted average sale price disclosed at $170.3278 with detailed lot-level price ranges provided in footnote 2.
- Trust-level ownership is itemized with explicit share counts for each trust, improving transparency about indirect holdings.
Negative
- Reported dispositions of common stock on 08/07/2025, which increases available shares in the market.
- Large indirect holdings concentrated in multiple trusts (e.g., Living Trust with 4,280,002 shares), which may affect perceptions of insider liquidity or control.
Insights
TL;DR: Insider sales executed under a prearranged 10b5-1 plan; detailed pricing and trust holdings disclosed — neutral without broader context.
The Form 4 shows planned dispositions of common stock executed under a Rule 10b5-1 plan, with a reported weighted average sale price of $170.3278 and lot-level ranges disclosed in footnote 2. Such prearranged plans typically reduce information asymmetry about timing, but the transactions still increase available float and warrant monitoring in the context of total insider holdings and outstanding shares.
TL;DR: Disclosure is transparent on mechanics and trust ownership; governance impact is neutral absent pattern or control changes.
The filing provides clear disclosure that the sales were pursuant to a 10b5-1 plan and offers granular price-range data upon request. It also lists substantial indirect holdings across multiple estate-planning trusts and includes customary disclaimers of beneficial ownership. From a governance perspective, properly documented, preplanned sales and explicit trust disclosures support transparency; they do not by themselves indicate a change in control or a governance event.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 25,423 | $170.3278 | $4.33M |
| Sale | Common Stock | 25,414 | $170.3278 | $4.33M |
| Sale | Common Stock | 25,420 | $170.3278 | $4.33M |
| Sale | Common Stock | 25,420 | $170.3278 | $4.33M |
| Sale | Common Stock | 25,420 | $170.3278 | $4.33M |
| Sale | Common Stock | 25,420 | $170.3278 | $4.33M |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024. The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
